RPS14 and neoplasm: The selective restoration of γ134.5 has been the basis for using α expression of Us11, chimeric oncolytic HSV/HCMV hybrids, partial deletion of γ134.5, and tumor-selective expression of γ134.5 or γ134.5 homologs to enhance oncolytic replication without restoring wild-type pathogenicity.